Dexamethasone versus Dexmedetomidine as Local Anesthetic Adjuvants in Ultrasound Guided Transversus Abdominis Plane Block for Total Abdominal Hysterectomies

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201604001577314

Enrollment

Registered

2016-04-10

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Fertility-female Anaesthesia

Interventions

Dexamethasone with bupivacain in TAPB

Dexmedetomidine with bupivacaine in TAPB

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients undergoing an abdominal hysterectomy. ASA I and II physical status.

Exclusion criteria

Exclusion criteria: Patient refusal. Body mass index (BMI) > 40. Patients with chronic pain. Those using chronic analgesic medications. Coagulopathy. Allergy to the study drugs. Patients taking other medications with ¿-adrenergic blocking effect. Hepatic or renal insufficiency. Systemic infection. Infection at the site of injection.

Design outcomes

Primary

Measure	Time frame
postoperative pain by visual analog scale (VAS)	—

Secondary

Measure	Time frame
intraoperative fentanyl consumption;Time to first analgesia (TFA) after operation ;Total morphine dose consumption in 24h postoperatively;Occurrence of postoperative nausea and vomiting;Assessment of alertness / sedation scale according to a five-point scale	—

Countries

Egypt

Contacts

Public ContactYasser Salim

Assisstant lecturer of anesthesia and ICU, faculty of medicine, Fayoum University

yasser.salem@yahoo.com00201009314178

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026